Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration

Author：

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.5, Iss.2, 2012-01, pp. : 580-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2156-2162

Spandidos Publications

Access to resources Recommend Favorite

Polyamines modulate the roscovitine-induced cell death switch decision autophagy vs. apoptosis in MCF-7 and MDA-MB-231 breast cancer cells

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4532-4540

Spandidos Publications

Access to resources Recommend Favorite

Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells

By Korah Reju Choi Lydia Barrios Judith Wieder Robert

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 319-322

Springer Publishing Company

Access to resources Recommend Favorite

PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 698-704

Spandidos Publications

Access to resources Recommend Favorite

Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 338-346

Spandidos Publications

Access to resources Recommend Favorite